申请人:Gitai Zemer
公开号:US20060241185A1
公开(公告)日:2006-10-26
The identification of MreB as essential for bacterial chromosome segregation provides a new target for antibiotic action. The MreB function is useful in the development of screening assays for new antibiotics, which may use, for example, genetic mutants in MreB, tests of MreB mediated chromosome segregation, and the like. In one embodiment of the invention, the antibiotic is an isothiourea compound, which may comprise a polyhalogenated benzyl group, e.g. at the 4 position, the 2,4 position, etc. A pharmaceutical composition comprising an MreB targeted antibiotic as an active agent is administered to a patient suffering from a microbial infection, particularly bacterial infections.
MreB的识别对于细菌染色体分离的必要性提供了新的抗生素作用靶点。MreB的功能对于开发用于新抗生素筛选的检测方法是有用的,这些方法可能包括MreB的遗传突变体、MreB介导的染色体分离等测试。在发明的一个实施例中,抗生素是一种异硫脲化合物,可能包括聚卤苯基,例如在4位、2,4位等位置。将以MreB为靶点的抗生素作为活性剂的药物组合物被用于治疗患有微生物感染,特别是细菌感染的患者。